On October 1, 2025, the Pharmacopoeia of the People's Republic of China (2025 Edition) was officially implemented. The new edition of the Pharmacopoeia sets forth more systematic and stringent requirements for the UV absorption performance of chromatography reagents, and adds several key wavelengths detection indicators.
Concord has proactively responded to the rising standards by upgrading their entire product line to ensure that our products strictly comply with all requirements of the Pharmacopoeia of the People's Republic of China (2025 Edition), Part 4, 8001 General Rules for Reagents. Furthermore, Concord has implemented enterprise standards that exceed those of the pharmacopoeia for key indicators of many critical solvents, providing higher quality reagents assurance for chromatographic analysis.
I.Quality indicators

II. Comprehensive Advantages of Concord Chromatography Reagents
1.More stringent quality standard system
Concord has set higher standards than the pharmacopoeia for the core wavelength of their solvents, with particular emphasis on controlling the low wavelength region of 200-230nm, to ensure that the reagents perform exceptionally well in high-sensitivity analysis and reduce background interference.
2.More comprehensive testing coverage
Based on covering all testing items in the pharmacopoeia, multiple quality control points have been added, and a more comprehensive UV absorption monitoring system has been established than the pharmacopoeia requirements, which can meet the needs of chromatographic method development and validation.
3. Stable production process control
By employing efficient distillation and purification processes combined with a comprehensive quality control system, batch-to-batch variations are reduced, ensuring stable and reliable quality.
4.Comprehensive quality documentation support
Each batch of products is provided with a detailed quality inspection report(COA), key parameters are traceable, and support laboratory audits, method validation, and regulatory compliance requirements.
Skype1